Letter: pathogenesis of tumour necrosis factor-alpha antagonists-induced psoriasiform lesions.
R
R
Denadai
F V
FV
Teixeira
R
R
Saad-Hossne
D000893:Anti-Inflammatory Agents / Q000009:adverse effects*; D003879:Dermatologic Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy*; D008727:Methotrexate / Q000627:therapeutic use*; D011565:Psoriasis / Q000188:drug therapy*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
D000893:Anti-Inflammatory Agents; D003879:Dermatologic Agents; D014409:Tumor Necrosis Factor-alpha; D008727:Methotrexate